UNIVERSITY OF WASHINGTON
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1861-01-01
- Employees
- 10K
- Market Cap
- -
Effect of Dihydrotestosterone (DHT) on Prostate Tissue [Short Title: DHT-3]
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: Placebo gel
- First Posted Date
- 2007-06-22
- Last Posted Date
- 2011-06-27
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 31
- Registration Number
- NCT00490022
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
PROS-1-Male Hormonal Contraceptive Regimens on Prostate Tissue
Phase 2
Completed
- Conditions
- Healthy
- Interventions
- Other: Placebo Testosterone gelDrug: Depo-Medroxyprogesterone (DMPA)Other: Placebo dutasterideOther: Placebo DMPA
- First Posted Date
- 2007-06-22
- Last Posted Date
- 2013-11-15
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 32
- Registration Number
- NCT00490555
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
Performance Evaluation and Research for Older Adults Requiring Major Surgery
Completed
- Conditions
- Healthy
- First Posted Date
- 2007-06-19
- Last Posted Date
- 2022-12-20
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 214
- Registration Number
- NCT00487890
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
Telephone Intervention After Traumatic Brain Injury
Not Applicable
Completed
- Conditions
- Brain Injuries
- Interventions
- Behavioral: Self-management telephone counseling
- First Posted Date
- 2007-06-07
- Last Posted Date
- 2012-06-20
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 433
- Registration Number
- NCT00483522
- Locations
- 🇺🇸
Methodist Rehabilitation Center, Jackson, Mississippi, United States
🇺🇸Moss Rehabilitation Research Institute, Philadelphia, Pennsylvania, United States
🇺🇸University of Washington, Seattle, Washington, United States
Telephone Follow-Up on Outcome After Mild Traumatic Brain Injury
Not Applicable
Completed
- Conditions
- Brain Concussion
- Interventions
- Behavioral: Scheduled telephone follow-up
- First Posted Date
- 2007-06-07
- Last Posted Date
- 2017-11-09
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 366
- Registration Number
- NCT00483444
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
Sweetened Beverages and Food Intake
Not Applicable
Completed
- Conditions
- OverweightObesity
- Interventions
- Behavioral: FructoseBehavioral: glucoseBehavioral: non-caloric sweetener
- First Posted Date
- 2007-05-21
- Last Posted Date
- 2012-05-02
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 10
- Registration Number
- NCT00475475
- Locations
- 🇺🇸
University of Washington General Clinical Research Center, Seattle, Washington, United States
ACY-6 Oral Administration of Acyline
- First Posted Date
- 2007-05-09
- Last Posted Date
- 2010-12-03
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 9
- Registration Number
- NCT00471185
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
62% & 15% Ethanol in Emollient Gel as Topical Male Microbicides
Phase 1
Completed
- Conditions
- Sexually Transmitted Infections
- Interventions
- Other: 62% ethanol in emollient gelDrug: PlaceboOther: 15% ethanol in emollient gel
- First Posted Date
- 2007-05-04
- Last Posted Date
- 2009-04-30
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 30
- Registration Number
- NCT00469547
- Locations
- 🇰🇪
Kenya Medical Research Institute, Kisumu, Kenya
Nurse-led Case Management for Diabetes and Cardiovascular Disease Patients With Depression
Not Applicable
Completed
- Conditions
- Depression
- Interventions
- Behavioral: Treatment as usualBehavioral: Nurse-led case management
- First Posted Date
- 2007-05-03
- Last Posted Date
- 2014-05-02
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 214
- Registration Number
- NCT00468676
- Locations
- 🇺🇸
Group Health Cooperative, Seattle, Washington, United States
Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy
Phase 2
Completed
- Conditions
- Ovarian Clear Cell CystadenocarcinomaStage IV Ovarian Epithelial CancerOvarian Endometrioid AdenocarcinomaPeritoneal Cavity CancerOvarian Serous CystadenocarcinomaOvarian Undifferentiated AdenocarcinomaBrenner TumorFallopian Tube CancerOvarian Mixed Epithelial CarcinomaOvarian Mucinous Cystadenocarcinoma
- Interventions
- Biological: sargramostimOther: laboratory biomarker analysisOther: immunologic technique
- First Posted Date
- 2007-04-27
- Last Posted Date
- 2017-08-28
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 21
- Registration Number
- NCT00466960
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
© Copyright 2025. All Rights Reserved by MedPath